Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer

Clinical trial NCT00316199 · COMPLETED

Trial details

NCT number: NCT00316199
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2006-04-01
Primary completion: 2008-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.